BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17335705)

  • 1. [Pegylated-interferon-associated retinopathy].
    Pérez-Alvarez MJ; Montes-Ramírez ML; Machín-Lázaro JM; Rodríguez-Zapata M
    Enferm Infecc Microbiol Clin; 2007 Mar; 25(3):217. PubMed ID: 17335705
    [No Abstract]   [Full Text] [Related]  

  • 2. Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
    Ogata H; Suzuki H; Shimizu K; Ishikawa H; Izumi N; Kurosaki M
    Jpn J Ophthalmol; 2006; 50(3):293-5. PubMed ID: 16767392
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blurred vision: cause? Retinopathy secondary to interferon treatment.
    Bowen DW; Vyas S
    Gut; 2006 Feb; 55(2):211, 251. PubMed ID: 16407386
    [No Abstract]   [Full Text] [Related]  

  • 5. Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.
    Bazarah SM; Ritenour R; Patel ST; Hirsch G; Peltekian KM; Cruess AF
    Ann Hepatol; 2006; 5(3):172-6. PubMed ID: 17060876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon].
    Salgado Ordóñez F; Manteca González R; Palacios Rodríguez S; Godoy Guerrero M
    Rev Clin Esp; 2005 Dec; 205(12):621-2. PubMed ID: 16527184
    [No Abstract]   [Full Text] [Related]  

  • 7. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon].
    Rosel L; Blanco JR; Metota L; Oteo JA
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon alfa, peginterferon alfa and retinopathy.
    Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C.
    Sheth HG; Michaelides M; Siriwardena D
    Indian J Ophthalmol; 2010; 58(2):147-8. PubMed ID: 20195039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
    Kim ET; Kim LH; Lee JI; Chin HS
    Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection.
    Willson RA
    J Clin Gastroenterol; 2004 Sep; 38(8):717-22. PubMed ID: 15319658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choreiform movements associated with pegylated interferon-alpha in a patient with chronic hepatitis C.
    Akin M; İşler M; Şenol A; Kutluhan S; Tüfekçı A
    Turk J Gastroenterol; 2012; 23(5):618-9. PubMed ID: 23161317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].
    Maede Y; Morishita K; Iwamura K; Takayama Y; Tsukada Y; Kishino M; Shimizu T; Matsushima S; Komatsu T; Kasagi Y
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2600-2. PubMed ID: 16419601
    [No Abstract]   [Full Text] [Related]  

  • 14. Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
    Cedar MA; Zancosky KL; Oliva LA; Molloy PJ; Weissgold DJ; Krawitt EL
    Am J Gastroenterol; 2007 Nov; 102(11):2612-3. PubMed ID: 17958775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy].
    Domínguez Gozalo A; Hidalgo Correas FJ; García Benayas E; García Díaz B
    Farm Hosp; 2015 May; 39(3):186-8. PubMed ID: 26005896
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinopathy in chronic hepatitis C patients during interferon treatment: a case report.
    Rossi C; Scotton PG; Farina F; Vaglia A
    Infez Med; 2010 Dec; 18(4):267-9. PubMed ID: 21196822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Has hepatitis C become curable by a new pegylated interferon?].
    Trépo C; Merle P
    Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
    Hara K; Tanito M; Ohira A
    Acta Ophthalmol; 2012 Mar; 90(2):e158-60. PubMed ID: 21649866
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis.
    Kang HY; Shin MC
    Korean J Ophthalmol; 2012 Apr; 26(2):147-50. PubMed ID: 22511844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
    Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
    Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.